The second major AD pathway is the tau-associated changes promoted by hyperphosphorylated tau somatodendritic accumulation, blocking the normal tau assembly to microtubules and precipitating neurofibrillary tangles. This evidence concerns the gene MAPT and Alzheimer disease.